|
Market Closed -
Nasdaq
04:00:00 2026-08-31 pm EDT
|
5-day change | 1st Jan Change | ||
| 91.06 USD | +0.26% |
|
-.--% | +37.20% |
| Aug. 24 | Dexcom Insider Sold Shares Worth $2,408,242, According to a Recent SEC Filing | MT |
| Aug. 13 | Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Medical Equipment, Supplies & Distribution
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 34.36B | |||||
| 191B | |||||
| 116B | |||||
| 61.75B | |||||
| 51.24B | |||||
| 51.51B |
- Stock Market
- Stocks
- DXCM Stock
- Charts DexCom, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
